Caspian Corporate Services Ltd vs Genomic Valley Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 16, 2026

Key Highlights

The Latest Trading Price of Caspian Corporate Services Ltd is ₹ 33.86 as of 16 Mar 15:30 . The P/E Ratio of Caspian Corporate Services Ltd changed from 37.6 on March 2022 to 29 on March 2025 . This represents a CAGR of -6.29% over 4 yearsThe P/E Ratio of Genomic Valley Biotech Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of Caspian Corporate Services Ltd changed from ₹ 18.7 crore on March 2022 to ₹ 73.3 crore on March 2025 . This represents a CAGR of 40.71% over 4 yearsThe Market Cap of Genomic Valley Biotech Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The revenue of Caspian Corporate Services Ltd for the Dec '25 is ₹ 26.13 crore as compare to the Sep '25 revenue of ₹ 22.86 crore. This represent the growth of 14.3% The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Caspian Corporate Services Ltd for the Dec '25 is ₹ 1.09 crore as compare to the Sep '25 ebitda of ₹ 1.24 crore. This represent the decline of -12.1% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Caspian Corporate Services Ltd changed from ₹ 3.09 crore to ₹ -0.08 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Caspian Corporate Services Ltd changed from 46.89 % on March 2023 to 0 % on March 2025 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Caspian Corporate Services Ltd

Caspian Corporate Services Limited was erstwhile incorporated in the name 'Intellivate Capital Advisors Limited' on March 3, 2011 as a Public Limited Company.
The Company received the Certificate of Commencement of Business on July 7, 2011.
The name of the Company was later on changed to 'Caspian Corporate Services Limited' from 'Intellivate Capital Advisors Limited' on February 17, 2022.
The Company is engaged in the business of providing Advisory & Consultancy Services. The Company is offering advisory services on several financial and corporate issues.
It enable corporate on raising funds through capital markets either through an IPO or FPO or regulatory advisory for issues such as takeover code and preferential allotments.

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

FAQs for the comparison of Caspian Corporate Services Ltd and Genomic Valley Biotech Ltd

Which company has a larger market capitalization, Caspian Corporate Services Ltd or Genomic Valley Biotech Ltd?

Market cap of Caspian Corporate Services Ltd is 43 Cr while Market cap of Genomic Valley Biotech Ltd is 7 Cr

What are the key factors driving the stock performance of Caspian Corporate Services Ltd and Genomic Valley Biotech Ltd?

The stock performance of Caspian Corporate Services Ltd and Genomic Valley Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Caspian Corporate Services Ltd and Genomic Valley Biotech Ltd?

As of March 16, 2026, the Caspian Corporate Services Ltd stock price is INR ₹34.25. On the other hand, Genomic Valley Biotech Ltd stock price is INR ₹24.99.

How do dividend payouts of Caspian Corporate Services Ltd and Genomic Valley Biotech Ltd compare?

To compare the dividend payouts of Caspian Corporate Services Ltd and Genomic Valley Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.